• MDS Congress 2026 Session 3411 Evaluation Form

  • Parallel Session 3411

    Tau Disorders – PSP and CBD: Homogeneity and Heterogeneity

    October 6, 2026

    14:30 - 16:00

  • Learning Objectives:

    1. Analyze the neuropathological variability within and between PSP and CBD subtypes
    2. Recognize the spectrum of clinical phenotypes associated with PSP and CBD type pathology
    3. Identify and evaluate emerging biomarkers relevant to PSP and CBD

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Hidetomo Tanaka, Japan

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Jacy Parmera, Brazil

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Carla Palleis, Germany

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: